Celtaxsys Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Celtaxsys

Access the complete profile.

Celtaxsys Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Address	201 17th St Nw Suite 530 Atlanta, GA 30363

Note: Revenues for privately held companies are statistical evaluations.


Celtaxsys's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Celtaxsys's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Celtaxsys is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Celtaxsys Annual Revenue and Growth Rate

Celtaxsys	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Celtaxsys's revenues are gauged from an analysis of company filings.

Celtaxsys's Income Statement (based on Industry Averages)

Celtaxsys P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Celtaxsys is developing and marketing. Celtaxsys doesn't have any recent trademark applications, indicating Celtaxsys is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CELTAXSYS Pharmaceutical preparations for the treatment of cancer, inflammatory diseases and infectious diseases	11/07/2011
THE INNATE IMMUNE COMPANY Pharmaceutical research and development	06/17/2011

See all trademarks and details in the Full Report.

Market Share of Celtaxsys's Largest Competitors

A competitive analysis shows these companies are in the same general field as Celtaxsys, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Celtaxsys. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ANGELINI PHARMA	Atlanta, GA	100
GENEXA	Atlanta, GA	18
ALLIANCE COMMUNITY PHARMACY	Atlanta, GA	6
JBS	Atlanta, GA	5
TRIDENT MEDICAL GROUP	Atlanta, GA	2
CELTAXSYS	Atlanta, GA	1

Future Competition: Celtaxsys's Fastest Growing Competitors

These companies are in the same general field as Celtaxsys and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)